<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NYSE:RDY (India) Also Trade In: Germany India Mexico

Dr Reddy's Laboratories Ltd $ 38.71 0.8 (2.11%)

Volume:
90,500
Avg Vol (1m):
166,471
Market Cap $:
6.42 Bil
Enterprise Value $:
6.52 Bil
P/E (TTM):
21.69
P/B:
3.09
Warning! GuruFocus has detected 2 Severe warning signs with RDY. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for RDY (Dr Reddy's Laboratories) from 2001 to Oct 20 2019. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Dr Reddy's Laboratories stock (RDY) PE ratio as of Oct 20 2019 is 21.69. More Details

Dr Reddy's Laboratories PE Ratio (TTM) Chart

EMBED

Dr Reddy's Laboratories PE Ratio (TTM) Historical Data

Total 1250
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Dr Reddy's Laboratories PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2019-10-2021.6 2019-08-1919.7
2019-10-1821.6 2019-08-1619.7
2019-10-1721.2 2019-08-1519.5
2019-10-1621.3 2019-08-1419.5
2019-10-1521.3 2019-08-1319.8
2019-10-1420.9 2019-08-1220.3
2019-10-1120.9 2019-08-0920.2
2019-10-1020.8 2019-08-0820.3
2019-10-0920.8 2019-08-0719.9
2019-10-0820.5 2019-08-0619.9
2019-10-0720.8 2019-08-0519.7
2019-10-0420.9 2019-08-0220.1
2019-10-0321.1 2019-08-0120.4
2019-10-0220.8 2019-07-3120.6
2019-10-0120.9 2019-07-3020.5
2019-09-3021.2 2019-07-2921.1
2019-09-2721.8 2019-07-2621.8
2019-09-2621.9 2019-07-2521.3
2019-09-2521.8 2019-07-2421.0
2019-09-2421.7 2019-07-2320.7
2019-09-2321.7 2019-07-2221.3
2019-09-2021.9 2019-07-1921.1
2019-09-1921.2 2019-07-1821.4
2019-09-1821.3 2019-07-1721.5
2019-09-1721.4 2019-07-1621.5
2019-09-1621.4 2019-07-1521.2
2019-09-1321.7 2019-07-1221.2
2019-09-1221.9 2019-07-1121.5
2019-09-1121.7 2019-07-1021.0
2019-09-1021.6 2019-07-0921.1
2019-09-0921.5 2019-07-0820.9
2019-09-0621.3 2019-07-0521.2
2019-09-0520.9 2019-07-0421.1
2019-09-0420.6 2019-07-0321.1
2019-09-0319.7 2019-07-0221.1
2019-09-0220.0 2019-07-0121.6
2019-08-3020.0 2019-06-2820.9
2019-08-2919.7 2019-06-2723.2
2019-08-2819.6 2019-06-2622.8
2019-08-2719.6 2019-06-2522.4
2019-08-2619.8 2019-06-2422.3
2019-08-2319.6 2019-06-2122.3
2019-08-2219.7 2019-06-2022.7
2019-08-2119.6 2019-06-1922.8
2019-08-2019.7 2019-06-1822.9

Dr Reddy's Laboratories PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Drug Manufacturers » Drug Manufacturers NAICS : 325412 NAICS : 2834
Address 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana, IND, 500 034
With headquarters in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceuticals. The firm operates in three divisions: global generics, proprietary products, and active chemical ingredients. The global generics and pharmaceutical services and active ingredients segments make up most of the company's revenue at about 80% and 17%, respectively. About 85% of Dr. Reddy's sales are based outside of India, with approximately 48% from North America and 12% from Europe.